Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 4/20 | 0.56 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.36 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.35 |
| ▸ | CDC25B | P30305 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6569564 | 1.00 | ALOX15 (0.56) | ALOX15EPHX2PTPN1ALDH1A1USP2 | |
| SCHEMBL7899333 | 0.92 | ALOX15 (0.49) | ALOX15EPHX2PTPN1ALDH1A1USP2 | |
| SCHEMBL7899335 | 0.92 | ALOX15 (0.49) | ALOX15EPHX2PTPN1ALDH1A1USP2 | |
| SCHEMBL6568238 | 0.90 | ALOX15 (0.46) | ALOX15EPHX2PTPN1ALDH1A1USP2 | |
| SCHEMBL6568241 | 0.90 | ALOX15 (0.46) | ALOX15EPHX2PTPN1ALDH1A1USP2 | |
| SCHEMBL10583022 | 0.87 | ALOX15 (0.69) | ALOX15EPHX2PTPN1ALDH1A1USP2 | |
| SCHEMBL22832776 | 0.85 | ALOX15 (0.75) | ALOX15EPHX2ALDH1A1USP2NFE2L2 | |
| SCHEMBL6567580 | 0.83 | ALOX15 (0.54) | ALOX15EPHX2PTPN1ALDH1A1USP2 | |
| SCHEMBL6567574 | 0.83 | ALOX15 (0.54) | ALOX15EPHX2PTPN1ALDH1A1USP2 | |
| SCHEMBL8840230 | 0.82 | ALOX15 (0.71) | ALOX15EPHX2PTPN1ALDH1A1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6207857-B1 | FOR ORGANOLEPTIC AND ANTIMICROBIAL COMPOUNDS GENERATED IN THE PRESENCE OF SKIN BACTERIA, ENZYMES OR ACIDIC OR ALKALINE CONDITIONS | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 2001-03-27 | — | — | US | claimed |
| EP-0887336-B1 | Precursor compounds | GIVAUDAN SA (CH) | 2004-01-07 | — | — | EP | disclosed |
| US-6207857-B1 | FOR ORGANOLEPTIC AND ANTIMICROBIAL COMPOUNDS GENERATED IN THE PRESENCE OF SKIN BACTERIA, ENZYMES OR ACIDIC OR ALKALINE CONDITIONS | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 2001-03-27 | — | — | US | disclosed |
| EP-0887336-A1 | Precursor Compounds | GIVAUDAN-ROURE (INTERNATIONAL) SA (CH) | 1998-12-30 | — | — | EP | disclosed |